Common use of TRANSPLANT PROCEDURES Clause in Contracts

TRANSPLANT PROCEDURES. The maximum amount payable for the transplan- tation of human organs, cells, and tissue benefit is six hundred thousand dollars (US$600,000) per insured, per diagnosis, per lifetime after the applicable deduct- ible. This transplant benefit begins once the need for transplantation has been determined by a physician, has been certified by a second surgical or medical opinion, and has been approved by USA Medical Services, and is subject to all the terms, provisions, and exclusions of the policy. This benefit includes: (a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, evaluation of the insured for the transplant procedure, and preparation and stabilization of the insured for the transplant procedure. (b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medications and supplies. (c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow, stem cell or cord blood storage or banking are covered up to a maximum of twenty-five thousand dollars (US$25,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit. (d) The hospitalization, surgeries, physician and surgeon’s fees, anesthesia, medi- cation, and any other treatment necessary during the transplant procedure. (e) Post-transplant care including, but not limited to any medically necessary follow-up treatment resulting from the transplant and any complications that arise after the transplant procedure, whether a direct or indirect consequence of the transplant. (f) Medication or therapeutic measures used to ensure the viability and perma- nence of the transplanted organ, cell or tissue. (g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusions, supplies, or medication related to the transplant.

TRANSPLANT PROCEDURES. The maximum amount payable for the transplan- tation of human organs, cells, and tissue benefit is six seven hundred fifty thousand dollars (US$600,000750,000) per insured, per diagnosis, per lifetime after the applicable deduct- ibleapplica- ble deductible. This transplant benefit begins once the need for transplantation has been determined by a physician, has been certified by a second surgical or medical opinion, and has been approved by USA Medical Services, and is subject to all the terms, provisions, and exclusions of the policy. This benefit includes: (a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, evaluation of the insured for the transplant procedure, and preparation and stabilization of the insured for the transplant procedure. (b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medications medi- cations and supplies. (c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow, stem cell or cord blood storage or banking are covered up to a maximum of twenty-five thousand dollars (US$25,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit. (d) The hospitalization, surgeries, physician and surgeon’s fees, anesthesia, medi- cation, and any other treatment necessary during the transplant procedure. (e) Post-transplant care including, but not limited to any medically necessary follow-up treatment resulting from the transplant and any complications that arise after the transplant procedure, whether a direct or indirect consequence of the transplant. (f) Medication or therapeutic measures used to ensure the viability and perma- nence of the transplanted organ, cell or tissue. (g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusionstransfu- sions, supplies, or medication related to the transplant.

TRANSPLANT PROCEDURES. The maximum amount payable for the transplan- tation of human organs, cells, and tissue benefit is six hundred thousand dollars (US$600,000) per insured, per diagnosis, per lifetime after the applicable deduct- ible. This transplant benefit begins once the need for transplantation has been determined by a physician, has been certified by a second surgical or medical opinion, and has been approved by USA Medical Services, and is subject to all the terms, provisions, and exclusions of the policy. This benefit includes: (a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, evaluation of the insured for the transplant procedure, and preparation and stabilization of the insured for the transplant procedure. (b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medications medica- tions and supplies. (c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow, stem cell or cord blood storage or banking are covered up to a maximum of twenty-five thousand dollars (US$25,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit. (d) The hospitalization, surgeries, physician and surgeon’s fees, anesthesia, medi- cation, and any other treatment necessary during the transplant procedure. (e) Post-transplant care including, but not limited to any medically necessary follow-up treatment resulting from the transplant and any complications that arise after the transplant procedure, whether a direct or indirect consequence of the transplant. (f) Medication or therapeutic measures used to ensure the viability and perma- nence of the transplanted organ, cell or tissue. (g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusionstransfu- sions, supplies, or medication related to the transplant.

TRANSPLANT PROCEDURES. The maximum amount payable for the transplan- tation of human organs, cells, and tissue benefit is six seven hundred fifty thousand dollars (US$600,000750,000) per insured, per diagnosis, per lifetime after the applicable deduct- ibledeductible. This transplant benefit begins once the need for transplantation has been determined by a physician, has been certified by a second surgical or medical opinion, and has been approved by USA Medical Services, and is subject to all the terms, provisions, and exclusions of the policy. This benefit includes: (a) Pre-transplant care, including those services directly related to evaluation of the need for transplantation, evaluation of the insured for the transplant procedure, and preparation and stabilization of the insured for the transplant procedure. (b) Pre-surgical workup, including all laboratory and X-ray exams, CT scans, Magnetic Resonance Imaging (MRI’s), ultrasounds, biopsies, scans, medications medi- cations and supplies. (c) The costs of organ, cell or tissue procurement, transportation, and harvesting including bone marrow, stem cell or cord blood storage or banking are covered up to a maximum of twenty-five thousand dollars (US$25,000) per diagnosis, which is included as part of the maximum transplant benefit. The donor workup, including testing of potential donors for a match is included in this benefit. (d) The hospitalization, surgeries, physician and surgeon’s fees, anesthesia, medi- cation, and any other treatment necessary during the transplant procedure. (e) Post-transplant care including, but not limited to any medically necessary follow-up treatment resulting from the transplant and any complications that arise after the transplant procedure, whether a direct or indirect consequence conse- quence of the transplant. (f) Medication or therapeutic measures used to ensure the viability and perma- nence of the transplanted organ, cell or tissue. (g) Home health care, nursing care (e.g. wound care, infusion, assessment, etc.), emergency transportation, medical attention, clinic or office visits, transfusions, supplies, or medication related to the transplant.